At 5mg/mL concentration, the same 0.02mL error on a 0.4mL draw represents only 5% error
These medications can curb your appetitebut without the right support, you risk losing muscle, energy, and essential nutrients along the way
"Wegovy should not be used in patients with a personal or family history of medullary thyroid carcinoma or in patients with a rare condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)," the FDA said in its news release
Common GLP-1 receptor agonists include semaglutide [1], marketed by Novo Nordisk as a once-weekly injection for T2DM (Ozempic), a once-weekly injection for chronic weight management (Wegovy), and a once daily oral tablet [2] for T2DM (Rybelsus)
Your body needs time to adjust to having sustained GLP-1 receptor activation rather than the brief pulses it normally experiences
Schedule with one of our providers to learn more about this weight management solution and discover how it can help you achieve your weight loss goals